Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Here's What to Expect From Moderna's Next Earnings Report

Moderna, Inc. (MRNA), headquartered in Cambridge, Massachusetts, is a leading biotechnology company committed to pioneering messenger RNA (mRNA) therapeutics and vaccines to transform the future of medicine. With a market cap of $15.9 billion, Moderna offers a diverse portfolio of mRNA-based vaccines and treatments across infectious diseases, immuno-oncology, and rare diseases. The company is set to announce its Q4 earnings on Thursday, Feb. 27.

Ahead of the event, analysts expect Moderna to report a loss of $2.94 per share, down 634.6% from the profit of $0.55 per share in the same quarter last year. The company has consistently surpassed Wall Street’s EPS estimates in each of its last four quarterly reports. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.